HB 2335 — Increasing access to medications for opioid use disorder.

H-4366.1SUBSTITUTEH-3696.1HOUSE HOUSE BILL 2335State of Washington66th Legislature2020 Regular SessionByHouseSessionByRepresentatives Health Care & Wellness (originally sponsored by Representatives Davis, Kilduff, Leavitt, Sells, Harris, Macri, Wylie, Doglio, Pollet, and Appleton)READAppletonPrefiled FIRST01/09/20.Read TIMEfirst 02/04/20.ANtime 01/13/20.Referred to Committee on Health Care & Wellness.AN ACT Relating to increasing access to medications for people with opioid use disorder;

addingand aamending newRCW section18.64.450.BE toIT chapterENACTED 18.64BY RCW;THE LEGISLATURE OF THE STATE OF WASHINGTON:Sec.

and creating a new section.BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF WASHINGTON:NEW SECTION.  Sec.

(1)RCW 18.64.450 and 2013 c 19 s 26 are each amended to read as follows:(1) In order for a health care entity to purchase, administer, dispense, and deliver legend drugs, the health care entity must be licensed by the department.(2) In order for a health care entity to purchase, administer, dispense, and deliver controlled substances, the health care entity must annually obtain a license from the department in accordance with the commission's rules.(3) The legislaturereceipt, declaresadministration, opioiddispensing, useand disorderdelivery isof legend drugs or controlled substances by a publichealth care entity must be performed under the supervision or at the direction of a pharmacist.(4) ((A))Except as provided in subsection (5) of this section, a health crisis.care entity may only administer, dispense, or deliver up to a seventy-two hour supply of legend drugs and controlled substances to patients who receive care within the health care entity and in compliance with rules of the commission.

Access((Nothing toin medicationsthis tosubsection treatshall thisprohibit diseasea needspractitioner, toin becarrying madeout readilyhis available,or especiallyher tolicensed vulnerableresponsibilities populationswithin whoa mayhealth notcare beentity, ablefrom dispensing or delivering to accessa medicalpatient careof orthe ahealth pharmacy.(2)care Theentity legislaturedrugs recognizesfor that increasedpatient's accesspersonal use in an amount not to buprenorphine,exceed asseventy-two wellhours asof additionalusage.))(5) medicationsA necessaryhealth care entity may only administer, dispense, or deliver up to aida intwo-week recovery,supply couldof benefitlegend individualsdrugs whoand arecontrolled sufferingsubstances fromto patients who receive evidence-based opioid use disorder.disorder treatment at the health care entity and in compliance with rules of the commission.--- END ---

The legislature further recognizes that access to pharmacies may be difficult for vulnerable populations.

To increase access to medications while ensuring patient safety the legislature intends to create a new credential to allow for a pharmacy license to be extended to a remote dispensing site where technology is used to dispense medications.NEW SECTION.  Sec.

2.

A new section is added to chapter 18.64 RCW to read as follows:(1) The license of location for a pharmacy licensed under this chapter may be extended to a remote dispensing site where technology is used to dispense medications approved by the United States food and drug administration for the treatment of opioid use disorder.(2) In order for a pharmacy to use remote dispensing sites, a pharmacy must register each separate remote dispensing site with the commission.(3) The commission shall adopt rules that establish minimum standards for remote dispensing sites registered under this section.

The minimum standards shall address who may retrieve medications for opioid use disorder stored in or at a remote dispensing site pursuant to a valid prescription or chart order.

The minimum standards must require the pharmacy be responsible for stocking and maintaining a perpetual inventory of the medications for opioid use disorder stored in or at the registered remote dispensing site.(4) The secretary may adopt rules to establish a reasonable fee for obtaining and renewing a registration issued under this section.(5) The registration issued under this section will be considered as part of the pharmacy license issued under RCW 18.64.043.

If the underlying pharmacy license is not active, then the registration shall be considered inoperable by operation of law.--- END ---